IMPLANT SURGERY
ACHIEVED
and longer for Barbara
IMPLANT SURGERY
and longer for Megan
IMPLANT SURGERY
SHARED
and longer for John
IMPLANT SURGERY
ACHIEVED
and longer for Barbara
IMPLANT SURGERY
and longer for Megan
IMPLANT SURGERY
SHARED
and longer for John
Longevity in Cardiac Care
Committed to providing the highest quality of care to our patients, our devices excel at predicting longevity and helping reduce replacements and re-interventions. Let’s hear Dr. De Sousa’s perspective on longevity, a cardiac electrophysiologist who has been implanting MicroPort® devices for nearly 30 years now.
BRADYCARDIA
Alizea
13 years1 longevity
with remote monitoring and full feature set ON
Greatest projected longevity with up to 42% additional battery life compared to other devices up to 14 cc2.
INCLUDING:
- Up to 22 minutes of EGM with pre-event EGM recordings
- Continuous Sleep Apnea Monitoring
- MV and G sensors for optimal rate adaptation
Thanks to an excellent longevity with remote monitoring, you can provide continuous and efficient patient care.
COMPARE THE COMPARABLE
Alizea & Eno
The Best ratio Longevity per Volume2
Optimized electronic placement, low intrinsic consumption and ellipse shape ensure no dead space, allowing MicroPort® to achieve the ideal ratio between size, shape and longevity for its latest pacemaker ranges.
- Eno™ is the world’s smallest transvenous pacemaker with the best longevity per cc
- Alizea™ and Eno™ dual chamber transvenous pacemakers have the best projected longevity per cc
Microport®’s ideal ratios
LONGEVITY PER VOLUME
Comparison across manufacturers based on 100% pacing in atrial and ventricular chambers**
** Conditions: DDDR mode 100 % A&V pacing 60min-1, 2.5V, 0.4ms, 500 Ω, sensor G ON, EGMs ON
*** Conditions: DDD mode 100 % A&V pacing 60min-1, 2.5V, 0.4ms, 500 Ω, sensor G OFF, EGMs ON
TACHYCARDIA
Unparalleled longevity4
Our devices incorporate advanced technology that withstands the test of time. Having the lowest current drain and a large battery capacity, MicroPort® excels in predicted longevity compared to other devices, saving patients from early replacements and alleviating the burden on healthcare systems.5,6
THE INTERACTIVE COMPARATOR
Designed to be more reliable, rugged, and long-lasting, discover how our products excel in predicted longevity when compared to other devices.
BRADYCARDIA
Click here to compare
TACHYCARDIA
Click here to compare
Sign up for our Newsletter
Subscribe and receive the latest news about our products.
REFERENCES
* For illustration purposes only.
Änsrapport 2022 Swedish ICD and PM Register; Annual Statistical Report 2020.
MicroPort® Sales data, 2013-2022.
1. SafeR mode, assuming 5% V pacing and 50% A pacing, 60 min-1, 2.5 V, 0.35 ms, 750 Ohms, Holter ON, sensors ON, Remote ON.
2. Competition comparison of transvenous pacemaker under 14cc made as of July 2022, refer to manufacturers’ manuals available online.
3. Versus previous pacemaker generation (Eno).
4. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
5. Borleffs CJ, Thijssen J, de Bie MK, van Rees JB, van Welsenes GH, van Erven L, Bax JJ, Cannegieter SC, Schalij MJ. Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol. 2010 Aug;33(8):1013-9.
6. Munawar DA, Mahajan R, Linz D, Wong GR, Khokhar KB, Thiyagarajah A, Kadhim K, Emami M, Mishima R, Elliott AD, Middeldorp ME, Roberts-Thompson KC, Young GD, Sanders P, Lau DH. Predicted longevity of contemporary cardiac implantable electronic devices: A call for industry-wide “standardized” reporting.Heart Rhythm. 2018 Dec; 15(12):1756-1763.
These products are not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.